Galectin Therapeutics
GALT
GALT
55 hedge funds and large institutions have $15.2M invested in Galectin Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
46% less capital invested
Capital invested by funds: $28.2M → $15.2M (-$13.1M)
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
Holders
55
Holding in Top 10
–
Calls
$759K
Puts
$348K
Top Buyers
| 1 | +$425K | |
| 2 | +$143K | |
| 3 | +$114K | |
| 4 |
SF
Synovus Financial
Columbus,
Georgia
|
+$99K |
| 5 |
Morgan Stanley
New York
|
+$90.1K |
Top Sellers
| 1 | -$529K | |
| 2 | -$311K | |
| 3 | -$164K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$121K |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
-$88K |